{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:10:28Z","timestamp":1767967828167,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":61,"publisher":"Springer US","isbn-type":[{"value":"9781071635605","type":"print"},{"value":"9781071635612","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3561-2_17","type":"book-chapter","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:02:21Z","timestamp":1704200541000},"page":"245-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Establishing a Pregnancy Lyme Disease Biobank"],"prefix":"10.1007","author":[{"given":"Stanley J.","family":"Naides","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"17_CR1","volume-title":"Developing and organizing an institutional biospecimen biorepository","author":"DF Hansel","year":"2014","unstructured":"Hansel DF, Jewell SD (2014) Developing and organizing an institutional biospecimen biorepository. CAP Press, Northfield"},{"issue":"6","key":"17_CR2","doi-asserted-by":"publisher","first-page":"e00449","DOI":"10.1128\/JCM.00449-20","volume":"58","author":"JL Schmitz","year":"2020","unstructured":"Schmitz JL (2020) Expanding access to biospecimens for Lyme disease test development. J Clin Microbiol 58(6):e00449\u2013e00420. https:\/\/doi.org\/10.1128\/JCM.00449-20","journal-title":"J Clin Microbiol"},{"issue":"6","key":"17_CR3","doi-asserted-by":"publisher","first-page":"e00032","DOI":"10.1128\/JCM.00032-20","volume":"8","author":"EJ Horn","year":"2020","unstructured":"Horn EJ, Dempsey G, Schotthoefer AM et al (2020) The Lyme disease biobank: characterization of 550 patient and control samples from the East Coast and Upper Midwest of the United States. J Clin Microbiol 8(6):e00032\u2013e00020. https:\/\/doi.org\/10.1128\/JCM.00032-20","journal-title":"J Clin Microbiol"},{"key":"17_CR4","unstructured":"Lyme Disease Biobank (2023). https:\/\/www.bayarealyme.org\/biobank\/. Accessed 4 Mar 2023"},{"key":"17_CR5","unstructured":"Centers for Disease Control and Prevention (2023) What is case surveillance? National Notifiable Diseases Surveillance Program (NNDSS). https:\/\/www.cdc.gov\/nndss\/about\/index.html. Accessed 4 Mar 2023"},{"issue":"32","key":"17_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","volume":"68","author":"P Mead","year":"2019","unstructured":"Mead P, Petersen J, Hinckley A (2019) Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep 68(32):703. https:\/\/doi.org\/10.15585\/mmwr.mm6832a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"17_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11908-014-0450-9","volume":"16","author":"RL DeBiasi","year":"2014","unstructured":"DeBiasi RL (2014) A concise critical analysis of serologic testing for the diagnosis of Lyme disease. Curr Infect Dis Rep 16(12):450. https:\/\/doi.org\/10.1007\/s11908-014-0450-9","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"17_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cll.2015.08.001","volume":"35","author":"ME Schriefer","year":"2015","unstructured":"Schriefer ME (2015) Lyme disease diagnosis: serology. Clin Lab Med 35(4):797\u2013814. https:\/\/doi.org\/10.1016\/j.cll.2015.08.001","journal-title":"Clin Lab Med"},{"key":"17_CR9","unstructured":"Centers for Disease Control and Prevention (2022) Lyme disease (Borrelia burgdorferi) 2022 case definition. National Notifiable Diseases Surveillance Program (NNDSS). https:\/\/ndc.services.cdc.gov\/case-definitions\/lyme-disease-2022\/. Accessed 4 Mar 2023"},{"issue":"7","key":"17_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1373\/clinchem.2014.228783","volume":"61","author":"C Ellervik","year":"2015","unstructured":"Ellervik C, Vaught J (2015) Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin Chem 61(7):914\u2013934. https:\/\/doi.org\/10.1373\/clinchem.2014.228783","journal-title":"Clin Chem"},{"key":"17_CR11","doi-asserted-by":"publisher","unstructured":"2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories. Biopreserv Biobank 10(2):79\u2013161. https:\/\/doi.org\/10.1089\/bio.2012.1022","DOI":"10.1089\/bio.2012.1022"},{"issue":"1","key":"17_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/bio.2018.0001","volume":"16","author":"LD Campbell","year":"2018","unstructured":"Campbell LD, Astrin JJ, DeSouza Y et al (2018) The 2018 revision of the ISBER best practices: summary of changes and the editorial team\u2019s development process. Biopreserv Biobank 16(1):3\u20136. https:\/\/doi.org\/10.1089\/bio.2018.0001","journal-title":"Biopreserv Biobank"},{"issue":"5","key":"17_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/bio.2019.0029","volume":"17","author":"R Tang","year":"2019","unstructured":"Tang R, She Q, Lu Y et al (2019) Quality control of RNA extracted from PAXgene blood RNA tubes after different storage periods. Biopreserv Biobank 17(5):477\u2013482. https:\/\/doi.org\/10.1089\/bio.2019.0029","journal-title":"Biopreserv Biobank"},{"issue":"1","key":"17_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s13104-020-05360-3","volume":"13","author":"LS Wylezinski","year":"2020","unstructured":"Wylezinski LS, Shaginurova GI, Spurlock CF III (2020) Longitudinal assessment and stability of long non-coding RNA gene expression profiles measured in human peripheral whole blood collected into PAXgene blood RNA tubes. BMC Res Notes 13(1):531. https:\/\/doi.org\/10.1186\/s13104-020-05360-3","journal-title":"BMC Res Notes"},{"issue":"4","key":"17_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1021\/pr050059a","volume":"4","author":"JL Hackett","year":"2005","unstructured":"Hackett JL, Gutman SI (2005) Introduction to the Food and Drug Administration (FDA) regulatory process. J Proteome Res 4(4):1110\u20131113. https:\/\/doi.org\/10.1021\/pr050059a","journal-title":"J Proteome Res"},{"issue":"Suppl 1","key":"17_CR16","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1471-2377-9-S1-S2","volume":"9","author":"KL Steinmetz","year":"2009","unstructured":"Steinmetz KL, Spack EG (2009) The basics of preclinical drug development for neurodegenerative disease indications. BMC Neurol 9(Suppl 1):S2. https:\/\/doi.org\/10.1186\/1471-2377-9-S1-S2","journal-title":"BMC Neurol"},{"issue":"RR-2","key":"17_CR17","first-page":"1","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC) (2012) Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. MMWR Recomm Rep 61(RR-2):1\u201344","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"17_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nbt.3237","volume":"33","author":"AS Gargis","year":"2015","unstructured":"Gargis AS, Kalman L, Bick DP et al (2015) Good laboratory practice for clinical next-generation sequencing informatics pipelines. Nat Biotechnol 33(7):689\u2013693. https:\/\/doi.org\/10.1038\/nbt.3237","journal-title":"Nat Biotechnol"},{"key":"17_CR19","unstructured":"Office for Human Research Protections. Regulations, Policy & Guidance. (2023). https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/index.html. Accessed 4 Mar 2023"},{"issue":"5","key":"17_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/1740774515597701","volume":"12","author":"MJ Welch","year":"2015","unstructured":"Welch MJ, Lally R, Miller JE et al (2015) The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials. Clin Trials 12(5):503\u2013510. https:\/\/doi.org\/10.1177\/1740774515597701","journal-title":"Clin Trials"},{"issue":"2","key":"17_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1556264616650802","volume":"11","author":"MA Yonas","year":"2016","unstructured":"Yonas MA, Jaime MC, Barone J et al (2016) Community partnered research ethics training in practice: a collaborative approach to certification. J Empir Res Hum Res Ethics 11(2):97\u2013105. https:\/\/doi.org\/10.1177\/1556264616650802","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"1","key":"17_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10903-017-0548-x","volume":"20","author":"J Kue","year":"2018","unstructured":"Kue J, Szalacha LA, Happ MB et al (2018) Culturally relevant human subjects protection training: a case study in community-engaged research in the United States. J Immigr Minor Health 20(1):107\u2013114. https:\/\/doi.org\/10.1007\/s10903-017-0548-x","journal-title":"J Immigr Minor Health"},{"issue":"3","key":"17_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1378\/chest.11-2182","volume":"141","author":"C Bova","year":"2012","unstructured":"Bova C, Drexler D, Sullivan-Bolyai S (2012) Reframing the influence of the health insurance portability and accountability act on research. Chest 141(3):782\u2013786. https:\/\/doi.org\/10.1378\/chest.11-2182","journal-title":"Chest"},{"issue":"2017","key":"17_CR24","first-page":"1044","volume":"16","author":"M Kayaalp","year":"2018","unstructured":"Kayaalp M (2018) Modes of de-identification. AMIA Annu Symp Proc 16(2017):1044\u20131050","journal-title":"AMIA Annu Symp Proc"},{"issue":"1","key":"17_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12911-017-0494-5","volume":"17","author":"T Takai-Igarashi","year":"2017","unstructured":"Takai-Igarashi T, Kinoshita K, Nagasaki M et al (2017) Security controls in an integrated Biobank to protect privacy in data sharing: rationale and study design. BMC Med Inform Decis Mak 17(1):100. https:\/\/doi.org\/10.1186\/s12911-017-0494-5","journal-title":"BMC Med Inform Decis Mak"},{"issue":"4","key":"17_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/gm239","volume":"3","author":"K El Emam","year":"2011","unstructured":"El Emam K (2011) Methods for the de-identification of electronic health records for genomic research. Genome Med 3(4):25. https:\/\/doi.org\/10.1186\/gm239","journal-title":"Genome Med"},{"issue":"2","key":"17_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/bio.2015.0073","volume":"14","author":"LA Matzke","year":"2016","unstructured":"Matzke LA, Fombonne B, Watson PH, Moore HM (2016) Fundamental considerations for biobank legacy planning. Biopreserv Biobank 14(2):99\u2013106. https:\/\/doi.org\/10.1089\/bio.2015.0073","journal-title":"Biopreserv Biobank"},{"issue":"2","key":"17_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/23294515.2020.1851313","volume":"12","author":"TJ Kasperbauer","year":"2021","unstructured":"Kasperbauer TJ, Schmidt KK, Thomas A et al (2021) Incorporating biobank consent into a healthcare setting: challenges for patient understanding. AJOB Empir Bioeth 12(2):113\u2013122. https:\/\/doi.org\/10.1080\/23294515.2020.1851313","journal-title":"AJOB Empir Bioeth"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fpubh.2020.00009","volume":"8","author":"MA Hathcock","year":"2020","unstructured":"Hathcock MA, Kirt C, Ryu E et al (2020) Characteristics associated with recruitment and re-contact in Mayo Clinic biobank. Front Public Health 8:9. https:\/\/doi.org\/10.3389\/fpubh.2020.00009","journal-title":"Front Public Health"},{"issue":"1","key":"17_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12910-022-00743-6","volume":"23","author":"N Antonova","year":"2022","unstructured":"Antonova N, Eritsyan K (2022) It is not a big deal: a qualitative study of clinical biobank donation experience and motives. BMC Med Ethics 23(1):7. https:\/\/doi.org\/10.1186\/s12910-022-00743-6","journal-title":"BMC Med Ethics"},{"issue":"1","key":"17_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41431-020-0701-1","volume":"29","author":"R Broekstra","year":"2020","unstructured":"Broekstra R, Aris-Meijer J, Maeckelberghe E (2020) Demographic and prosocial intrapersonal characteristics of biobank participants and refusers: the findings of a survey in The Netherlands. Eur J Hum Genet 29(1):11\u201319. https:\/\/doi.org\/10.1038\/s41431-020-0701-1","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"17_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12910-020-00504-3","volume":"21","author":"R Broekstra","year":"2020","unstructured":"Broekstra R, Maeckelberghe ELM, Aris-Meijer J et al (2020) Motives of contributing personal data for health research: (non-)participation in a Dutch biobank. BMC Med Ethics 21(1):62. https:\/\/doi.org\/10.1186\/s12910-020-00504-3","journal-title":"BMC Med Ethics"},{"issue":"1","key":"17_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/cge.12370","volume":"86","author":"JE Olson","year":"2014","unstructured":"Olson JE, Bielinski SJ, Ryu E et al (2014) Biobanks and personalized medicine. Clin Genet 86(1):50\u201355. https:\/\/doi.org\/10.1111\/cge.12370","journal-title":"Clin Genet"},{"issue":"3","key":"17_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1748-720X.2011.00619.x","volume":"39","author":"C Strong","year":"2011","unstructured":"Strong C (2011) Minimal risk in research involving pregnant women and fetuses. J Law Med Ethics 39(3):529\u2013538. https:\/\/doi.org\/10.1111\/j.1748-720X.2011.00619.x","journal-title":"J Law Med Ethics"},{"issue":"1","key":"17_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jme.20.1.36","volume":"20","author":"F Anderson","year":"1994","unstructured":"Anderson F, Glasier A, Ross J, Baird DT (1994) Attitudes of women to fetal tissue research. J Med Ethics 20(1):36\u201340. https:\/\/doi.org\/10.1136\/jme.20.1.36","journal-title":"J Med Ethics"},{"issue":"5","key":"17_CR36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.stemcr.2019.10.003","volume":"13","author":"JM McCune","year":"2019","unstructured":"McCune JM, Weissman IL (2019) The ban on US government funding research using human Fetal tissues: how does this fit with the NIH Mission to advance medical science for the benefit of the citizenry? Stem Cell Rep 13(5):777\u2013786. https:\/\/doi.org\/10.1016\/j.stemcr.2019.10.003","journal-title":"Stem Cell Rep"},{"issue":"12","key":"17_CR37","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/j.stemcr.2021.10.016","volume":"16","author":"KE MacDuffie","year":"2021","unstructured":"MacDuffie KE, Hyun I, Krogen MM et al (2021) Rescuing human fetal tissue research in the United States: a call for additional regulatory reform. Stem Cell Rep 16(12):2839\u20132843. https:\/\/doi.org\/10.1016\/j.stemcr.2021.10.016","journal-title":"Stem Cell Rep"},{"issue":"1","key":"17_CR38","first-page":"61","volume":"17","author":"EA Largent","year":"2017","unstructured":"Largent EA, Fernandez Lynch H (2017) Paying research participants: regulatory uncertainty, conceptual confusion, and a path forward. Yale J Health Policy Law Ethics 17(1):61\u2013141","journal-title":"Yale J Health Policy Law Ethics"},{"issue":"3","key":"17_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11019-022-10092-1","volume":"25","author":"J R\u00f3\u017cy\u0144ska","year":"2022","unstructured":"R\u00f3\u017cy\u0144ska J (2022) The ethical anatomy of payment for research participants. Med Health Care Philos 25(3):449\u2013464. https:\/\/doi.org\/10.1007\/s11019-022-10092-1","journal-title":"Med Health Care Philos"},{"issue":"4","key":"17_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045717","volume":"11","author":"A Martani","year":"2021","unstructured":"Martani A, Genevi\u00e8ve LD, Elger B, Wangmo T (2021) \u2018It\u2019s not something you can take in your hands\u2019. Swiss experts\u2019 perspectives on health data ownership: an interview-based study. BMJ Open 11(4):e045717. https:\/\/doi.org\/10.1136\/bmjopen-2020-045717","journal-title":"BMJ Open"},{"issue":"7","key":"17_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129893","volume":"10","author":"Y Joly","year":"2015","unstructured":"Joly Y, Dalp\u00e9 G, So D, Birko S (2015) Fair shares and sharing fairly: a survey of public views on open science, informed consent and participatory research in biobanking. PLoS One 10(7):e0129893. https:\/\/doi.org\/10.1371\/journal.pone.0129893","journal-title":"PLoS One"},{"issue":"6","key":"17_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/GIM.0b013e318211a9c2","volume":"13","author":"RJ Cadigan","year":"2011","unstructured":"Cadigan RJ, Easter MM, Dobson AW et al (2011) \u201cThat\u2019s a good question\u201d: university researchers\u2019 views on ownership and retention of human genetic specimens. Genet Med 13(6):569\u2013575. https:\/\/doi.org\/10.1097\/GIM.0b013e318211a9c2","journal-title":"Genet Med"},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12910-015-0020-1","volume":"16","author":"AJ Goldenberg","year":"2015","unstructured":"Goldenberg AJ, Maschke KJ, Joffe S et al (2015) IRB practices and policies regarding the secondary research use of biospecimens. BMC Med Ethics 16:32. https:\/\/doi.org\/10.1186\/s12910-015-0020-1","journal-title":"BMC Med Ethics"},{"issue":"8","key":"17_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049228","volume":"11","author":"C Ohmann","year":"2021","unstructured":"Ohmann C, Moher D, Siebert M et al (2021) Status, use and impact of sharing individual participant data from clinical trials: a scoping review. BMJ Open 11(8):e049228. https:\/\/doi.org\/10.1136\/bmjopen-2021-049228","journal-title":"BMJ Open"},{"key":"17_CR45","unstructured":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) (2023) Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) Data Sharing and Publication Policy. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/adni.loni.usc.edu\/wp-content\/uploads\/how_to_apply\/ADNI_DSP_Policy.pdf. Accessed 4 Mar 2023"},{"issue":"8","key":"17_CR46","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/hbm.25803","volume":"43","author":"AS Jwa","year":"2022","unstructured":"Jwa AS, Poldrack RA (2022) The spectrum of data sharing policies in neuroimaging data repositories. Hum Brain Mapp 43(8):2707\u20132721. https:\/\/doi.org\/10.1002\/hbm.25803","journal-title":"Hum Brain Mapp"},{"key":"17_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.967310","volume":"9","author":"G Bonizzi","year":"2022","unstructured":"Bonizzi G, Zattoni L, Capra M et al (2022) Standard operating procedures for biobank in oncology. Front Mol Biosci 9:967310. https:\/\/doi.org\/10.3389\/fmolb.2022.967310","journal-title":"Front Mol Biosci"},{"issue":"1","key":"17_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/advances\/nmaa088","volume":"12","author":"KC Maki","year":"2021","unstructured":"Maki KC, Miller JW, McCabe GP et al (2021) Perspective: laboratory considerations and clinical data Management for human nutrition randomized controlled trials: guidance for ensuring quality and integrity. Adv Nutr 12(1):46\u201358. https:\/\/doi.org\/10.1093\/advances\/nmaa088","journal-title":"Adv Nutr"},{"issue":"1","key":"17_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/bio.2015.0061","volume":"14","author":"SY Nussbeck","year":"2016","unstructured":"Nussbeck SY, Rabone M, Benson EE et al (2016) Life in data--outcome of a multi-disciplinary, interactive biobanking conference session on sample data. Biopreserv Biobank 14(1):56\u201364. https:\/\/doi.org\/10.1089\/bio.2015.0061","journal-title":"Biopreserv Biobank"},{"issue":"2","key":"17_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12687-011-0070-0","volume":"3","author":"H Gottweis","year":"2012","unstructured":"Gottweis H, Lauss G (2012) Biobank governance: heterogeneous modes of ordering and democratization. J Community Genet 3(2):61\u201372. https:\/\/doi.org\/10.1007\/s12687-011-0070-0","journal-title":"J Community Genet"},{"issue":"1","key":"17_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/bio.2013.0064","volume":"12","author":"PH Watson","year":"2014","unstructured":"Watson PH, Nussbeck SY, Carter C et al (2014) A framework for biobank sustainability. Biopreserv Biobank. 12(1):60\u201368. https:\/\/doi.org\/10.1089\/bio.2013.0064","journal-title":"Biopreserv Biobank."},{"issue":"5","key":"17_CR52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/gb-2012-13-5-158","volume":"13","author":"ES Dove","year":"2012","unstructured":"Dove ES, Joly Y, Knoppers BM (2012) Power to the people: a wiki-governance model for biobanks. Genome Biol 13(5):158. https:\/\/doi.org\/10.1186\/gb-2012-13-5-158","journal-title":"Genome Biol"},{"issue":"2","key":"17_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/biotech10020007","volume":"10","author":"ML Hartung","year":"2021","unstructured":"Hartung ML, Baber R, Herpel E et al (2021) Harmonization of biobank education for biobank technicians: identification of learning objectives. BioTech (Basel) 10(2):7. https:\/\/doi.org\/10.3390\/biotech10020007","journal-title":"BioTech (Basel)"},{"issue":"4","key":"17_CR54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/02611929221113976","volume":"50","author":"A Chr\u00f3\u015bcicka","year":"2022","unstructured":"Chr\u00f3\u015bcicka A, Paluch A, Kalaszczy\u0144ska I, Szab\u0142owska-Gadomska I (2022) Biobank personnel \u2013 the key to its success. Altern Lab Anim 50(4):275\u2013281. https:\/\/doi.org\/10.1177\/02611929221113976","journal-title":"Altern Lab Anim"},{"issue":"11","key":"17_CR55","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41431-018-0228-x","volume":"26","author":"H Langhof","year":"2018","unstructured":"Langhof H, Kahrass H, Illig T et al (2018) Current practices for access, compensation, and prioritization in biobanks. Results from an interview study. Eur J Hum Genet 26(11):1572\u20131581. https:\/\/doi.org\/10.1038\/s41431-018-0228-x","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"17_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/bio.2015.0076","volume":"13","author":"CY Seiler","year":"2015","unstructured":"Seiler CY, Eschbacher J, Bowser R, LaBaer J (2015) Sustainability in a hospital-based biobank and university-based DNA biorepository: strategic roadmaps. Biopreserv Biobank 13(6):401\u2013409. https:\/\/doi.org\/10.1089\/bio.2015.0076","journal-title":"Biopreserv Biobank"},{"issue":"1","key":"17_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12967-019-02187-w","volume":"18","author":"IC Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez IC, Merino IG, Mu\u00f1oz-Fern\u00e1ndez M\u00c1 (2020) Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank. J Transl Med 18(1):6. https:\/\/doi.org\/10.1186\/s12967-019-02187-w","journal-title":"J Transl Med"},{"issue":"2","key":"17_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/bio.2017.0009","volume":"15","author":"T Croxton","year":"2017","unstructured":"Croxton T, Swanepoel C, Musinguzi H et al (2017) Lessons learned from biospecimen shipping among the human heredity and health in Africa biorepositories. Biopreserv Biobank 15(2):103\u2013110. https:\/\/doi.org\/10.1089\/bio.2017.0009","journal-title":"Biopreserv Biobank"},{"key":"17_CR59","unstructured":"Indian Council of Medical Research (2023) Transfer of Biological Material. https:\/\/main.icmr.nic.in\/content\/transfer-biological-material. Accessed 4 Mar 2023"},{"key":"17_CR60","unstructured":"U.S. Customs and Border Protection (2021) Importing biological materials into the United States. https:\/\/www.cbp.gov\/trade\/basic-import-export\/importing-biological-materials-united-states. Accessed 4 Mar 2023"},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6939-15-4","volume":"15","author":"K Moodley","year":"2014","unstructured":"Moodley K, Sibanda N, February K, Rossouw T (2014) \u201cIt\u2019s my blood\u201d: ethical complexities in the use, storage and export of biological samples: perspectives from South African research participants. BMC Med Ethics 15:4. https:\/\/doi.org\/10.1186\/1472-6939-15-4","journal-title":"BMC Med Ethics"}],"container-title":["Methods in Molecular Biology","Borrelia burgdorferi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3561-2_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:03:23Z","timestamp":1704200603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3561-2_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071635605","9781071635612"],"references-count":61,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3561-2_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"3 January 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}